Drug Trial Radar · NCT07069725
The Phase 1, Open-label, PET Trial Designed to Investigate the Effect of AZD2389 on FAP Occupancy in the Liver in Participants With Advanced Liver Fibrosis.
Last checked: Nov 19, 2026Latest source record: Jul 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
8
Actual
Start
May 26, 2025
Primary completion
Jul 2, 2026
Study completion Jul 2, 2026
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- Collaborators
- CTC Clinical Trial Consultants AB; Karolinska Institutet
- First posted
- Jul 17, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 20 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a phase 1, open-label, PET trial. The study is designed to investigate the effect of AZD2389 on FAP occupancy in the liver in participants with advanced liver fibrosis.
Conditions
- Liver Fibrosis
- Hepatic Cirrhosis
Interventions
AZD2389Drug
Doses of AZD2389 will be administrated orally
PET scan and radioligandDiagnostic test
PET scan and radioligand
Primary outcomes
What the sponsor says the trial is designed to measure.
- Occupancy, %: percent change from baseline in uptake of FAP PET radioligand [68Ga]Ga-FAPI-46 in the liver after a single dose of AZD2389.Time frame: PART B: Day 7(+/-2 days); PART C: Day 2 and Day 8 (+/-2 days)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Research Site
Stockholm, Sweden
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.